Neo's Magnet Milestone Comes With a $450 Million Bill—and a Feedstock Question
A huge guidance raise and Europe's first commercial magnet shipments are real; the next leg depends on grants, scrap and a Phase 1b sanction management still won't pull forward.
NEO.TO · Earnings Call · 2026-11-10
The quarter Neo stopped asking investors to take magnets on faith
Neo Performance Materials has spent several quarters arguing that customer demand for rare earth magnets was not the bottleneck. In Q3 2026 it had something more tangible: commercial production at its European magnet facility, with sintered magnets shipping to a European Tier 1 traction-motor customer. Rahim Suleman called it “the milestone that the industry has been watching for, commercial production at our European magnet facility” — Rahim Suleman, Chief Executive Officer · 2026-11-10. That is the operative change. Neo is no longer only a critical-materials optionality story; it is a qualified industrial supplier with a much larger capital agenda attached.
The guidance raise is real—but it is still a pricing story first
The headline numbers were exceptional: Q3 revenue of $194 million, up nearly 60%; adjusted EBITDA of $47 million, up almost 150% from $19 million; adjusted EPS of $0.40 versus $0.14. Year-to-date adjusted EBITDA reached roughly $140 million, up 150% from $55 million. Management then did something it has done repeatedly this year: raised guidance again.
we're raising our 2026 adjusted EBITDA guidance to $180 million to $185 million, up from our prior range of $140 million to $150 million.
At the midpoint that is 26% above the prior range and about 2.4x 2025's $76 million. But the mix matters. Rare Metals generated $88 million of revenue, up almost 125%, and $35 million of adjusted EBITDA, up over 200%, on tight supply and elevated hafnium, gallium and rhenium pricing. That is favorable pricing meeting global supply scarcity, not a brand-new demand curve. Magnequench and Chemicals & Oxides grew too—up 25% and nearly 70% at the EBITDA line—but the quarter's earnings torque still came from rare metals. The August call had already flagged that Neo assumed minimal hafnium spot sales in the second half; Q3 instead benefited from higher contracted hafnium volumes for Q4. The raise is real, but it is partly a scarcity-price mark-to-market.
Europe is now a capital-markets story, not just an industrial one
The more important strategic event was the European Union Innovation Fund selection: a grant of up to EUR126 million, or about $140 million, for an integrated magnet project that now carries total CapEx of roughly $450 million. The project bundles three things Neo had previously discussed separately: Silmet 2.0 separation facility expansion, new metallization capacity, and Phase 1b expansion of the magnet facility from about 2,000 to 5,000 tons. At least one-third of the additional 3,000 tons is earmarked for EU offshore wind farm demand. The grant is non-dilutive and comes with priority permitting and access to EU debt channels—genuinely different from a standard industrial expansion.
But the capital stack is the tension. Jonathan Baksh said the separation and metallization step is “an order of magnitude greater than what Silmet 1.0 can do today” — Jonathan Baksh, Chief Financial Officer · 2026-11-10, which is why the project is no longer a simple Phase 1b bolt-on. Management insists it will phase the spending and tie it to customer demand, not build all at once. That is consistent with prior calls, when Rahim Suleman described the Phase 1b decision as “primarily one related to timing, and that's really just about capital efficiency” — Ian Gillies, Analyst · 2025-11-14. The difference now is that the number is bigger and the funding toolkit is broader. Investors can underwrite the grant; they still cannot underwrite the final sanction timing.
Feedstock is the open switch
Neo has been careful to say demand is not the constraint. The constraint is feed. Suleman was blunt: “The only open switch, frankly, is feedstock” — Rahim Suleman, Chief Executive Officer · 2026-11-10. The Carester term sheet and Rainbow Rare Earths MOU are the answer so far—offtake rights to 40% of Rainbow's NdPr oxide and 65% of its mixed heavy rare earth carbonate, plus a recycling loop for magnet swarf. These are sensible, asset-light ways to fill a separator without owning a mine. They also explain why the equity story is no longer just "Europe needs magnets." Europe imports about 25,000 tons of permanent magnets annually, more than 90% from a single jurisdiction, but Neo still has to prove it can source the right rare earth basket at the right impurity profile and price. The grant de-risks the balance sheet; feedstock de-risks the P&L. The same theme is visible across the critical-materials peer group, where rare earth separation capacity outside China remains the scarce step.
What fell out of the spotlight
Two quieter shifts are worth flagging. First, water treatment ranked as a top company keyword this quarter, yet management went out of its way to call it small. Suleman said it is “probably still a smallish business in '27” — Rahim Suleman, Chief Executive Officer · 2026-11-10. The keyword is strategically interesting because it is an outlet for non-magnetic separated materials, but it is not yet a financial driver. Second, bonded magnets—the business Suleman previously said “just gets overlooked in that universe” — Rahim Suleman, CEO · 2026-08-11—were a solid contributor in Q3 but no longer the lead story. The narrative has rotated from bonded cash flow to European sintered-magnet capex, separation and metallization. That is the right rotation if the grant and feedstock strategy work; it also means the company's risk profile now hinges more on project execution than on legacy volume growth.
The Q3 call is best read as a company crossing a threshold: it proved it can make automotive-grade magnets in Europe, and it secured a large public grant to build the chain backward into separation and metallization. The guidance raise is the applause line. The real question is whether Neo can convert a $450 million project, a $140 million grant and a still-unfinished feedstock book into durable returns before the scarcity pricing that is currently flattering Rare Metals normalizes. Management has been consistent that demand is not the issue. The market's job now is to watch the two things management cannot fully control: feedstock contracts and Phase 1b sanction timing.